An emergency department nurse is providing handoff communication using SBAR (situation, background, assessment, recommendations) to the nurse accepting a client in the intensive care unit. The emergency department nurse reports that the client will require a suction set up for gastric tube drainage and will need an endoscopy performed. Which of the following parts of the SBAR report is the nurse communicating?

A. Respiratory acidosis: Clients with COPD have chronic difficulty exhaling carbon dioxide due to airflow obstruction, leading to CO₂ retention. This accumulation of carbon dioxide causes a drop in blood pH, resulting in respiratory acidosis, a common acid-base imbalance in COPD patients.
B. Metabolic acidosis: Metabolic acidosis results from increased acid production or loss of bicarbonate through the kidneys or gastrointestinal tract, such as in diabetic ketoacidosis or severe diarrhea. It is not typically associated with impaired ventilation or chronic lung disease like COPD.
C. Respiratory alkalosis: Respiratory alkalosis occurs when there is excessive loss of carbon dioxide due to hyperventilation. Clients with COPD generally hypoventilate rather than hyperventilate, making this acid-base imbalance unlikely in this case.
D. Metabolic alkalosis: Metabolic alkalosis is typically caused by loss of hydrogen ions through vomiting or diuretic use, or excessive bicarbonate intake. It is unrelated to the impaired gas exchange and CO₂ retention seen in clients with COPD.

A. Glatiramer acetate: Glatiramer acetate is an immunomodulatory drug used primarily to treat multiple sclerosis by reducing the frequency of relapses. It has no role in the treatment of spasm-induced incontinence and does not affect bladder muscle activity, making it irrelevant to the client’s condition.
B. Dulaglutide: Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes. It works by enhancing insulin secretion and slowing gastric emptying but has no effect on neurogenic bladder or incontinence associated with spinal cord injury.
C. Oxybutynin: Oxybutynin is an anticholinergic medication that relaxes the bladder's detrusor muscle, reducing urinary frequency and urgency. It is commonly prescribed for clients with neurogenic bladder or spasm-induced incontinence following spinal cord injury, making it the most appropriate choice.
D. Montelukast sodium: Montelukast sodium is a leukotriene receptor antagonist used to prevent asthma symptoms and allergic rhinitis. It does not affect bladder function or spasticity and would not be prescribed for incontinence related to spinal cord injury.